TNBC also exhibits a unique tumor microenvironment, being the most immune-activated breast cancer subtype by tumor-infiltrating lymphocytes (TILs) levels, expression of the programmed death-ligand 1 (PDL1) protein, and immune-gene expression signatures13. This evidence concerns the gene CD274 and neoplasm.